Biogen Inc. (ETR:IDP)
157.00
-0.35 (-0.22%)
At close: Nov 28, 2025
Biogen Market Cap
Biogen has a market cap or net worth of €23.04 billion as of November 28, 2025. Its market cap has decreased by -0.32% in one year.
Market Cap
23.04B
Enterprise Value
25.31B
Revenue
8.58B
Ranking
n/a
PE Ratio
16.80
Stock Price
€157.00
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 126.71M to 23.04B, an increase of 18,080.45%. That is a compound annual growth rate of 16.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 23.04B | 7.03% |
| Dec 31, 2024 | 21.52B | -36.55% |
| Dec 29, 2023 | 33.92B | -9.09% |
| Dec 30, 2022 | 37.31B | 20.41% |
| Dec 31, 2021 | 30.99B | 0.60% |
| Dec 31, 2020 | 30.80B | -35.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 50.43B |
| Siemens Healthineers AG | 47.80B |
| Bayer Aktiengesellschaft | 29.95B |
| Fresenius SE & Co. KGaA | 26.66B |
| Sartorius Aktiengesellschaft | 15.41B |
| Fresenius Medical Care AG | 11.88B |
| Carl Zeiss Meditec AG | 3.90B |
| Fielmann Group AG | 3.68B |